USD
$0.00
(0.00%
)At Close (As of Sep 12, 2025)
$1.53B
Market Cap
-
P/E Ratio
-1.44
EPS
$55.33
52 Week High
$24.07
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $133M |
Total Revenue | $313M |
Cost Of Revenue | $180M |
Costof Goods And Services Sold | $180M |
Operating Income | -$221M |
Selling General And Administrative | $218M |
Research And Development | $91M |
Operating Expenses | $354M |
Investment Income Net | - |
Net Interest Income | $15M |
Interest Income | $15M |
Interest Expense | $29K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $31M |
Income Before Tax | -$208M |
Income Tax Expense | $560K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$209M |
Comprehensive Income Net Of Tax | - |
Ebit | -$208M |
Ebitda | -$177M |
Net Income | -$209M |
Field | Value (USD) |
---|---|
Total Assets | $614M |
Total Current Assets | $347M |
Cash And Cash Equivalents At Carrying Value | $226M |
Cash And Short Term Investments | $226M |
Inventory | $24M |
Current Net Receivables | $35M |
Total Non Current Assets | $268M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $14M |
Intangible Assets Excluding Goodwill | $14M |
Goodwill | $86M |
Investments | - |
Long Term Investments | - |
Short Term Investments | $50M |
Other Current Assets | $11M |
Other Non Current Assets | - |
Total Liabilities | $142M |
Total Current Liabilities | $71M |
Current Accounts Payable | $1.6M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $15M |
Total Non Current Liabilities | $71M |
Capital Lease Obligations | $85M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $85M |
Other Current Liabilities | $35M |
Other Non Current Liabilities | $407K |
Total Shareholder Equity | $473M |
Treasury Stock | - |
Retained Earnings | -$1.2B |
Common Stock | - |
Common Stock Shares Outstanding | $58M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$64M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $31M |
Capital Expenditures | $5.1M |
Change In Receivables | - |
Change In Inventory | $8M |
Profit Loss | - |
Cashflow From Investment | -$3.1M |
Cashflow From Financing | $6.9M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | -$4M |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$209M |
Field | Value (USD) |
---|---|
Gross Profit | $133M |
Total Revenue | $313M |
Cost Of Revenue | $180M |
Costof Goods And Services Sold | $180M |
Operating Income | -$221M |
Selling General And Administrative | $218M |
Research And Development | $91M |
Operating Expenses | $354M |
Investment Income Net | - |
Net Interest Income | $15M |
Interest Income | $15M |
Interest Expense | $29K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $31M |
Income Before Tax | -$208M |
Income Tax Expense | $560K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$209M |
Comprehensive Income Net Of Tax | - |
Ebit | -$208M |
Ebitda | -$177M |
Net Income | -$209M |
Sector: HEALTHCARE
Industry: DIAGNOSTICS & RESEARCH
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company is headquartered in South San Francisco, California.